Tapewire

Nasdaq · USD

ICUI

ICU MEDICAL INC/DE

Export transactions ↓
Tapewire entity
2385
SEC CIK
0000883984
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202608
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2023 Filed Mar 8, 2023 21:59 UTC
Voigtlander Christian B.Chief Operating Officer
Exercise / conversionCommon Stock 8,745 $0.00 $0.00
Disclosure

SEC source: 0001727477-23-000001 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:06 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionPerformance Shares · Derivative 1,595 $0.00 $0.00
Disclosure

SEC source: 0001669639-23-000001 · edgardoc.xml · derivative · entry 9

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,595 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:06 UTC
Sanzone Virginia RuthVP, General Counsel
Tax withholdingCommon Stock 839 $161.25 $135,288.75
Disclosure

SEC source: 0001669639-23-000001 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,802

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:06 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionCommon Stock 1,595 $0.00 $0.00
Disclosure

SEC source: 0001669639-23-000001 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionPerformance Shares · Derivative 9,994 $0.00 $0.00
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 13

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,994 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock · Derivative 1,773 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 10

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,773 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Tax withholdingCommon Stock 5,261 $161.25 $848,336.25
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,042

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock 9,994 $0.00 $0.00
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,303

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Tax withholdingCommon Stock 933 $161.25 $150,446.25
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,309

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:56 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock 1,773 $0.00 $0.00
Disclosure

SEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,242

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionPerformance Shares · Derivative 8,745 $0.00 $0.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 12

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,745 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock · Derivative 1,551 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 9

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,551 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Tax withholdingCommon Stock 4,604 $161.25 $742,395.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 4

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,353

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock 8,745 $0.00 $0.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,957

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Tax withholdingCommon Stock 816 $161.25 $131,580.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,212

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:52 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock 1,551 $0.00 $0.00
Disclosure

SEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
February 02, 2023 Filed Feb 2, 2023 19:57 UTC
Woolson DanielVP, GM-Infusion Capital
SaleCommon Stock 1,731 $200.00 $346,200.00
Disclosure

SEC source: 0001698998-23-000001 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,152

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2022.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
November 15, 2022 Filed Nov 15, 2022 22:24 UTC
Sanzone Virginia RuthVP, General Counsel
SaleCommon Stock 325 $160.12 $52,039.00
Disclosure

SEC source: 0001669639-22-000003 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,046

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2022.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
September 21, 2022 Filed Sep 21, 2022 21:36 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 79,576 $0.00 Strike: $61.76 $0.00
Disclosure

SEC source: 0001073397-22-000002 · edgardoc.xml · derivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 79,576 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

Read SEC document
September 21, 2022 Filed Sep 21, 2022 21:36 UTC Exercise / conversionCommon Stock 79,576 $61.76 $4,914,613.76
Disclosure

SEC source: 0001073397-22-000002 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 23, 2022 Filed May 23, 2022 20:42 UTC
Jain VivekDirector · Chairman and CEO
GiftCommon Stock 30 $0.00 $0.00
Disclosure

SEC source: 0001410442-22-000003 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,469

F1 · price: This was a bona fide gift with no payment in consideration

Read SEC document
May 17, 2022 Filed May 18, 2022 16:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001209191-22-029950 · doc4.xml · derivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:25 UTC GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029950 · doc4.xml · derivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:20 UTC GrantNon-Quakified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001209191-22-029949 · doc4.xml · derivative · entry 2

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:20 UTC GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029949 · doc4.xml · derivative · entry 1

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:14 UTC
Abbey DonaldDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001209191-22-029948 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:14 UTC
Abbey DonaldDirector
GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029948 · doc4.xml · derivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001209191-22-029947 · doc4.xml · derivative · entry 3

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:07 UTC GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029947 · doc4.xml · derivative · entry 2

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 15:52 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001871884-22-000002 · edgardoc.xml · derivative · entry 2

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 15:52 UTC GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871884-22-000002 · edgardoc.xml · derivative · entry 1

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 15:47 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001645866-22-000002 · edgardoc.xml · derivative · entry 2

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 15:47 UTC GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001645866-22-000002 · edgardoc.xml · derivative · entry 1

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2022 Filed May 18, 2022 16:07 UTC GiftCommon Stock 743 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029947 · doc4.xml · nonDerivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,190

Read SEC document
May 12, 2022 Filed May 12, 2022 20:53 UTC
Sanzone Virginia RuthVP, General Counsel
SaleCommon Stock 750 $173.56 $130,170.00
Disclosure

SEC source: 0001669639-22-000002 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,371

F1 · security: These securities are Restricted Stock Units.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
May 12, 2022 Filed May 12, 2022 19:30 UTC SaleCommon Stock 217 $170.53 $37,005.01
Disclosure

SEC source: 0001209191-22-028504 · doc4.xml · nonDerivative · entry 2

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,933

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 1, 2022.

F4 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
May 12, 2022 Filed May 13, 2022 20:55 UTC PurchaseCommon Stock 17 $174.66 $2,969.22
Disclosure

SEC source: 0001073397-22-000001 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,444

F5 · price: All shares sold were purchased at the exact price disclosed.

Read SEC document
May 12, 2022 Filed May 13, 2022 20:55 UTC PurchaseCommon Stock 9,329 $174.17 $1,624,838.46
Disclosure

SEC source: 0001073397-22-000001 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,427

F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $173.64 to $174.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Read SEC document
May 12, 2022 Filed May 13, 2022 20:55 UTC PurchaseCommon Stock 7,092 $173.07 $1,227,443.64
Disclosure

SEC source: 0001073397-22-000001 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,098

F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $172.64 to $173.61, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Read SEC document
May 12, 2022 Filed May 13, 2022 20:55 UTC PurchaseCommon Stock 4,917 $172.24 $846,885.40
Disclosure

SEC source: 0001073397-22-000001 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,006

F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $171.64 to $172.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Read SEC document
May 12, 2022 Filed May 13, 2022 20:55 UTC PurchaseCommon Stock 4,480 $170.79 $765,119.04
Disclosure

SEC source: 0001073397-22-000001 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,089

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $170.42 to $171.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:30 UTC Exercise / conversionCommon Stock · Derivative 433 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028504 · doc4.xml · derivative · entry 3

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 433 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:30 UTC Exercise / conversionCommon Stock 433 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028504 · doc4.xml · nonDerivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:17 UTC Exercise / conversionCommon Stock · Derivative 129 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028501 · doc4.xml · derivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 129 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:17 UTC Exercise / conversionCommon Stock 129 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028501 · doc4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:07 UTC Exercise / conversionCommon Stock · Derivative 433 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028500 · doc4.xml · derivative · entry 2

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 433 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:07 UTC Exercise / conversionCommon Stock 433 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028500 · doc4.xml · nonDerivative · entry 1

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:00 UTC
Abbey DonaldDirector
Exercise / conversionCommon Stock · Derivative 433 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028497 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 433 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:00 UTC
Abbey DonaldDirector
Exercise / conversionCommon Stock 433 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028497 · doc4.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 11, 2022 Filed May 12, 2022 18:38 UTC Exercise / conversionCommon Stock · Derivative 352 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871884-22-000001 · edgardoc.xml · derivative · entry 2

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 352 shares

Expires 2022-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards were a proration of the 2021 Director equity grant and vest on the one-year anniversary from the 5/11/2021 Director equity grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.